Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14,700 JPY | +0.93% | +2.15% | -9.73% |
04-12 | Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months | MT |
04-12 | COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.73% | 3.81B | |
-0.73% | 3.44B | |
-23.44% | 3.15B | |
+7.98% | 2.76B | |
+17.83% | 2.71B | |
-9.90% | 1.79B | |
+11.26% | 1.43B | |
-19.60% | 974M | |
-36.03% | 710M | |
-0.53% | 454M |
- Stock Market
- Equities
- 3349 Stock
- News COSMOS Pharmaceutical Corporation
- UBS Adjusts Cosmos Pharmaceutical's Price Target to 16,500 Yen From 17,500 Yen, Keeps at Neutral